Cargando…

Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis

Tuberculosis (TB) elimination requires innovative approaches. The new Global Tuberculosis Network (GTN) aims to conduct research on key unmet therapeutic and diagnostic needs in the field of TB elimination using multidisciplinary, multisectorial approaches. The TB Pharmacology section within the new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alffenaar, Jan-Willem C, Gumbo, Tawanda, Dooley, Kelly E, Peloquin, Charles A, Mcilleron, Helen, Zagorski, Andre, Cirillo, Daniela M, Heysell, Scott K, Silva, Denise Rossato, Migliori, Giovanni Battista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146003/ https://www.ncbi.nlm.nih.gov/pubmed/31560376 http://dx.doi.org/10.1093/cid/ciz942

Ejemplares similares

Rifampin Pharmacokinetics/Pharmacodynamics in the Hollow-Fiber Model of Mycobacterium kansasii Infection
por: Srivastava, Shashikant, et al.
Publicado: (2022)

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
por: Alghamdi, Wael A., et al.
Publicado: (2019)

Global TB Network: working together to eliminate tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo Experiments
por: Liu, Yongge, et al.
Publicado: (2023)

Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration
por: Gumbo, Tawanda, et al.
Publicado: (2021)

Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
por: Alffenaar, Jan-Willem C., et al.
Publicado: (2022)

The Fontan Operation is Not the End of the Road
por: Caneo, Luiz Fernando, et al.
Publicado: (2016)

Practices of therapeutic drug monitoring in tuberculosis: an international survey
por: Margineanu, Ioana, et al.
Publicado: (2022)

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection
por: Al-Shaer, Mohammad H., et al.
Publicado: (2019)

Tuberculosis series 2020
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Tuberculosis series 2019
por: Silva, Denise Rossato, et al.
Publicado: (2019)

Tuberculosis Series 2021
por: Silva, Denise Rossato, et al.
Publicado: (2021)

Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities
por: Esposito, Susanna, et al.
Publicado: (2021)

Precision Therapy for Invasive Fungal Diseases
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Shortened tuberculosis treatment regimens: what is new?
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Diagnosis and management of post-tuberculosis lung disease
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Effects of COVID-19 on tuberculosis control: past, present, and future
por: Silva, Denise Rossato, et al.
Publicado: (2022)

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground
por: Srivastava, Shashikant, et al.
Publicado: (2016)

Implementing molecular tuberculosis diagnostic methods in limited-resource and high-burden countries
por: Vasiliu, Anca, et al.
Publicado: (2022)

Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study
por: Heysell, Scott K, et al.
Publicado: (2022)

Rolling out new anti-tuberculosis drugs without diagnostic capacity
por: Ness, Tara, et al.
Publicado: (2023)

Tuberculosis series
por: Silva, Denise Rossato, et al.
Publicado: (2018)

1659. Pharmacokinetics/pharmacodynamics of the Novel Gyrase Inhibitor SPR719/SPR720 and Clinical Dose Selection to Treat Pulmonary Mycobacterium avium-complex Disease
por: Deshpande, Devyani, et al.
Publicado: (2020)

Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
por: Deshpande, Devyani, et al.
Publicado: (2022)

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis
por: Migliori, Giovanni Battista, et al.
Publicado: (2019)

Increasingly powerful opioid antagonists are not necessary
por: Hill, Lucas G., et al.
Publicado: (2022)

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis
por: Rockwood, Neesha, et al.
Publicado: (2017)

Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in Children
por: Srivastava, Shashikant, et al.
Publicado: (2020)

Innovations triggered by India’s bold vision to end tuberculosis
por: Sahu, Suvanand
Publicado: (2023)

Reframing the approach to heterosexual men in the HIV epidemic in sub‐Saharan Africa
por: Makusha, Tawanda, et al.
Publicado: (2020)

Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis Complex
por: Tornheim, Jeffrey A, et al.
Publicado: (2019)

Migration and medical screening for tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2021)

Ending discrimination in healthcare
por: Amon, Joseph J
Publicado: (2020)

End-to-End Lymphaticovenular Anastomosis Does Not Disturb the Contraction of Collecting Lymph Vessels
por: Nuri, Takashi, et al.
Publicado: (2017)

Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis
por: Shenje, Justin, et al.
Publicado: (2015)

Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Eliminating tuberculosis in Latin America: making it the point
por: Duarte, Raquel, et al.
Publicado: (2018)

COVID-19 is, in the end, an endothelial disease
por: Libby, Peter, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8odbk2lujltvuohso0945h5ril